OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial
Shengli Xia, Jialiang Du, Jia Su, et al.
Vaccine (2020) Vol. 38, Iss. 46, pp. 7393-7400
Open Access | Times Cited: 29
Shengli Xia, Jialiang Du, Jia Su, et al.
Vaccine (2020) Vol. 38, Iss. 46, pp. 7393-7400
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Karla Soares‐Weiser, Harriet MacLehose, Hanna Bergman, et al.
Cochrane database of systematic reviews (2012)
Closed Access | Times Cited: 359
Karla Soares‐Weiser, Harriet MacLehose, Hanna Bergman, et al.
Cochrane database of systematic reviews (2012)
Closed Access | Times Cited: 359
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Hanna Bergman, Nicholas Henschke, Daniel Hungerford, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 68
Hanna Bergman, Nicholas Henschke, Daniel Hungerford, et al.
Cochrane library (2021) Vol. 2021, Iss. 11
Open Access | Times Cited: 68
Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
Benjamin Lee
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 6, pp. 1787-1802
Open Access | Times Cited: 44
Benjamin Lee
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 6, pp. 1787-1802
Open Access | Times Cited: 44
Effect of rotavirus genetic diversity on vaccine impact
Asma Sadiq, Nazish Bostan, Jadoon Khan, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Closed Access | Times Cited: 38
Asma Sadiq, Nazish Bostan, Jadoon Khan, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 1
Closed Access | Times Cited: 38
Rotavirus vaccines: progress and new developments
Jordan Cates, Jacqueline E. Tate, Umesh D. Parashar
Expert Opinion on Biological Therapy (2021) Vol. 22, Iss. 3, pp. 423-432
Open Access | Times Cited: 35
Jordan Cates, Jacqueline E. Tate, Umesh D. Parashar
Expert Opinion on Biological Therapy (2021) Vol. 22, Iss. 3, pp. 423-432
Open Access | Times Cited: 35
Safety, Immunogenicity, and Mechanism of a Rotavirus mRNA-LNP Vaccine in Mice
Chenxing Lu, Yan Li, Rong Chen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 211-211
Open Access | Times Cited: 5
Chenxing Lu, Yan Li, Rong Chen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 211-211
Open Access | Times Cited: 5
Correlates of immune protection against human rotaviruses: natural infection and vaccination
Tayebeh Latifi, Atefeh Kachooei, Somayeh Jalilvand, et al.
Archives of Virology (2024) Vol. 169, Iss. 3
Closed Access | Times Cited: 5
Tayebeh Latifi, Atefeh Kachooei, Somayeh Jalilvand, et al.
Archives of Virology (2024) Vol. 169, Iss. 3
Closed Access | Times Cited: 5
Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years
Ziwei Sun, Yu Fu, Hailing Lu, et al.
JAMA Pediatrics (2021) Vol. 175, Iss. 7, pp. e210347-e210347
Open Access | Times Cited: 29
Ziwei Sun, Yu Fu, Hailing Lu, et al.
JAMA Pediatrics (2021) Vol. 175, Iss. 7, pp. e210347-e210347
Open Access | Times Cited: 29
Human rotavirus strains circulating among children in the capital of China (2018–2022)_ predominance of G9P[8] and emergence ofG8P[8]
Yang Jiao, Taoli Han, Xiaoqi Ma, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18236-e18236
Open Access | Times Cited: 11
Yang Jiao, Taoli Han, Xiaoqi Ma, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18236-e18236
Open Access | Times Cited: 11
Rotavirus vaccine effectiveness and coverage among children younger than 5 years old in Shanghai, China: A test-negative case control study
Xiaohuan Gong, Zhuoying Huang, Yaxu Zheng, et al.
Vaccine (2025) Vol. 48, pp. 126731-126731
Closed Access
Xiaohuan Gong, Zhuoying Huang, Yaxu Zheng, et al.
Vaccine (2025) Vol. 48, pp. 126731-126731
Closed Access
Whole-Genome Analysis of G2P[4] Rotavirus Strains in China in 2022 and Comparison of Their Antigenic Epitopes with Vaccine Strains
R Che, Jiaxin Fan, Guangping Xiong, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 326-326
Open Access
R Che, Jiaxin Fan, Guangping Xiong, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 326-326
Open Access
Diverse processes in rotavirus vaccine development
Xiaochen Lin, Hongjun Li
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Xiaochen Lin, Hongjun Li
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial
Yan Liu, Guang-Wei Feng, Jinyuan Wu, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 369-369
Open Access
Yan Liu, Guang-Wei Feng, Jinyuan Wu, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 369-369
Open Access
The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers
Jessie Chen, Stephanie Grow, Miren Iturriza‐Gómara, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2565-2565
Open Access | Times Cited: 15
Jessie Chen, Stephanie Grow, Miren Iturriza‐Gómara, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2565-2565
Open Access | Times Cited: 15
Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs
Jiahao Wang, Haijun Zhang, Haonan Zhang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 10
Jiahao Wang, Haijun Zhang, Haonan Zhang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 10
Impact of vaccination with different types of rotavirus vaccines on the incidence of intussusception: a randomized controlled meta-analysis
Guoyong Wang, Kaijun Zhang, Rensen Zhang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 6
Guoyong Wang, Kaijun Zhang, Rensen Zhang, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 6
Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease
Viviana Parreño, Muqun Bai, Fangning Liu, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1529-1529
Open Access | Times Cited: 9
Viviana Parreño, Muqun Bai, Fangning Liu, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1529-1529
Open Access | Times Cited: 9
Prevalence and genotypes distribution of group A rotavirus among outpatient children under 5 years with acute diarrhea in Shanghai, China, 2012–2018
Lijuan Lu, Huaqing Zhong, Ran Jia, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Lijuan Lu, Huaqing Zhong, Ran Jia, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Rotavirus
Khitam Muhsen, Muna Omar
Elsevier eBooks (2024), pp. 2321-2338
Closed Access | Times Cited: 1
Khitam Muhsen, Muna Omar
Elsevier eBooks (2024), pp. 2321-2338
Closed Access | Times Cited: 1
Effectiveness of Lanzhou Lamb Rotavirus Vaccine and RotaTeq Against Hospitalized Rotavirus Infections Among Children During 2020-2023 in Guangdong Province, China: A Test-Negative Case-Control Study
Yi Yao, Jun Liu, Yingtao Zhang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2301-2317
Open Access | Times Cited: 1
Yi Yao, Jun Liu, Yingtao Zhang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2301-2317
Open Access | Times Cited: 1
Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment
Wenwen Ma, Liujin Zhang, Deyu Ren, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Wenwen Ma, Liujin Zhang, Deyu Ren, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Genotype analysis of rotaviruses isolated from children during a phase III clinical trial with the hexavalent rotavirus vaccine in China
Wenqi Zou, Qingchuan Yu, Yan Liu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 6, pp. 889-899
Open Access | Times Cited: 2
Wenqi Zou, Qingchuan Yu, Yan Liu, et al.
Virologica Sinica (2023) Vol. 38, Iss. 6, pp. 889-899
Open Access | Times Cited: 2
Application of the cell‐based RT‐qPCR assay (C‐QPA ) for potency detection of the novel trivalent rotavirus vaccine in China
Yunjin Wang, Yueyue Liu, Hong Bao, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 23-24
Open Access | Times Cited: 2
Yunjin Wang, Yueyue Liu, Hong Bao, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 23-24
Open Access | Times Cited: 2
Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China
Shuning Chen, Shenghui Gao, Jingxin Li, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 547-554
Closed Access | Times Cited: 3
Shuning Chen, Shenghui Gao, Jingxin Li, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 547-554
Closed Access | Times Cited: 3
Progress in research and development of preventive vaccines for children in China
XuYang Zheng, Jin Ge
Frontiers in Pediatrics (2024) Vol. 12
Open Access
XuYang Zheng, Jin Ge
Frontiers in Pediatrics (2024) Vol. 12
Open Access
